Quantitative analysis of image metrics for reduced and standard dose pediatric 18F-FDG PET/MRI examinations
- PMID: 30673306
- PMCID: PMC6541180
- DOI: 10.1259/bjr.20180438
Quantitative analysis of image metrics for reduced and standard dose pediatric 18F-FDG PET/MRI examinations
Abstract
Objective:: The study performs a comprehensive analysis of image metrics to objectively support the reduction of injected activity in pediatric oncology 18F-FDG PET/MR (18F-fludeoxyglucose PET/MR) examinations. Contrast-to-Noise Ratio (CNR), Normalized Noise (NN), tumor burden, and standardized uptake value (SUV) parameters stability were investigated to robustly define the acceptable reduced activity level that preserves the clinical utility of images, considering different PET applications.
Methods:: 21 PET/MRI examinations performed on a 3-Tesla Biograph mMR scanner were analyzed. Tracer activity reduction was stimulated by decreasing the count statistics of the original list-mode data (3 MBq kg-1). In addition to the already studied SUV metrics and subjective scoring on lesion detectability, a thorough analysis of CNR, NN, Metabolic Tumor Volume (MTV), and Total Lesion Glycolysis (TLG) was performed.
Results:: SUVmax and SUVmean increased more than 5% only in 0.6 MBq kg-1 reconstructed images (+10% and +9%, respectively), while SUVpeak was almost unaffected (average variations < 2%). The quantified CNR, NN, MTV, and TLG behavior with the decrease of the injected activity clearly defines 1.5 MBq kg-1 as a threshold of activity after which the quality of the image degrades. Subjective and objective analyses yielded consistent results. All 56 lesions were detected until activity of 1.2 MBq kg-1, whereas five lesions were missed on the 0.6 MBq kg-1 image. Perceived image quality (IQ) decreased in Lower Tracer Activity (LTA) images but remained acceptable until 1.5 MBq kg-1.
Conclusion:: Results about the stability of image metrics beyond the semi-quantitative SUV parameters and subjective analysis, rigorously proves the feasibility of the reduction of injected activity to 1.5 MBqkg-1 for pediatric patients aged between 7 and 17 years.
Advances in knowledge:: This is the first report on the quantitative evaluation of the effect of activity reduction on image quality in pediatric PET/MR. The findings offer objective corroboration to the feasibility of a significant dose reduction without consequences on clinical image reading and tumor burden metrics.
Figures






Similar articles
-
Quantitative and visual analyses of the effect of activity reduction on image metrics and quality in 18F-FDG PET/MRI in pediatric oncology.Turk J Med Sci. 2023 Feb;53(1):289-302. doi: 10.55730/1300-0144.5584. Epub 2023 Feb 22. Turk J Med Sci. 2023. PMID: 36945939 Free PMC article.
-
Defining optimal tracer activities in pediatric oncologic whole-body 18F-FDG-PET/MRI.Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2283-2289. doi: 10.1007/s00259-016-3503-5. Epub 2016 Aug 26. Eur J Nucl Med Mol Imaging. 2016. PMID: 27565153
-
Simulation of Tracer Dose Reduction in 18F-FDG PET/MRI: Effects on Oncologic Reading, Image Quality, and Artifacts.J Nucl Med. 2017 Oct;58(10):1699-1705. doi: 10.2967/jnumed.116.184440. Epub 2017 Mar 30. J Nucl Med. 2017. PMID: 28360205
-
Feasibility and performance of an adaptive contrast-oriented FDG PET/CT quantification technique for global disease assessment of malignant pleural mesothelioma and a brief review of the literature.Hell J Nucl Med. 2015 Jan-Apr;18(1):11-8. doi: 10.1967/s002449910162. Epub 2015 Feb 13. Hell J Nucl Med. 2015. PMID: 25679073 Review.
-
Assessing PET Parameters in Oncologic 18F-FDG Studies.J Nucl Med Technol. 2020 Sep;48(3):278-282. doi: 10.2967/jnmt.119.236109. Epub 2019 Dec 6. J Nucl Med Technol. 2020. PMID: 31811061 Review.
Cited by
-
Quantitative and visual analyses of the effect of activity reduction on image metrics and quality in 18F-FDG PET/MRI in pediatric oncology.Turk J Med Sci. 2023 Feb;53(1):289-302. doi: 10.55730/1300-0144.5584. Epub 2023 Feb 22. Turk J Med Sci. 2023. PMID: 36945939 Free PMC article.
-
Imaging of pediatric extragonadal pelvic soft tissue tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.Pediatr Blood Cancer. 2023 Jun;70 Suppl 4(Suppl 4):e29966. doi: 10.1002/pbc.29966. Epub 2022 Dec 8. Pediatr Blood Cancer. 2023. PMID: 36482882 Free PMC article.
-
Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0.Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3852-3869. doi: 10.1007/s00259-022-05817-6. Epub 2022 May 10. Eur J Nucl Med Mol Imaging. 2022. PMID: 35536420 Free PMC article.
-
Imaging of pediatric extremity soft tissue tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.Pediatr Blood Cancer. 2023 Jun;70 Suppl 4(Suppl 4):e29944. doi: 10.1002/pbc.29944. Epub 2022 Sep 7. Pediatr Blood Cancer. 2023. PMID: 36070194 Free PMC article.
-
[18F] Sodium Fluoride Dose Reduction Enabled by Digital Photon Counting PET/CT for Evaluation of Osteoblastic Activity.Front Med (Lausanne). 2022 Jan 12;8:725118. doi: 10.3389/fmed.2021.725118. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35096851 Free PMC article.
References
-
- Franzius C. FDG-PET/CT in pediatric solid tumors. Q J Nucl Med Mol Imaging 2010; 54: 401–10. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical